These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18237692)

  • 21. Microvascular function, diabetes and coronary risk.
    Gutiérrez E
    Int J Cardiol; 2020 May; 307():176-177. PubMed ID: 32115271
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of type 2 diabetes mellitus on aortic elastic properties in normotensive diabetes: Doppler tissue imaging study.
    Mahfouz Badran H; Elnoamany M
    J Am Soc Echocardiogr; 2006 Dec; 19(12):1471-81. PubMed ID: 17138032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome.
    Sucato V; Novo G; Evola S; Novo S
    Int J Cardiol; 2015; 186():96-7. PubMed ID: 25814352
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationale and pitfalls of noninvasive coronary flow reserve estimation in assessment of microvascular disease.
    Koshy SK; Govindarajan G
    Echocardiography; 2012 Jul; 29(6):631-3. PubMed ID: 22775231
    [No Abstract]   [Full Text] [Related]  

  • 25. (F)Utility of invasive haemodynamic measurements to guide percutaneous intervention in chronic coronary artery disease.
    Seiler C
    Swiss Med Wkly; 2015; 145():w14143. PubMed ID: 26151732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary flow reserve evaluation in stress-echocardiography laboratory.
    Rigo F; Gherardi S; Galderisi M; Cortigiani L
    J Cardiovasc Med (Hagerstown); 2006 Jul; 7(7):472-9. PubMed ID: 16801808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive coronary physiology for assessing intermediate lesions.
    Fearon WF
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001942. PubMed ID: 25657316
    [No Abstract]   [Full Text] [Related]  

  • 28. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
    Lerman A; Holmes DR; Herrmann J; Gersh BJ
    Eur Heart J; 2007 Apr; 28(7):788-97. PubMed ID: 17347176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic evaluation and clinical implications of aortic stiffness and coronary flow reserve and their relation.
    Nemes A; Geleijnse ML; Forster T; Soliman OI; Ten Cate FJ; Csanády M
    Clin Cardiol; 2008 Jul; 31(7):304-9. PubMed ID: 17957740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing flow limitation in patients with stable coronary artery disease.
    Townend JN; Ludman PF; Doshi SN; Khan H; Calvert PA
    BMJ; 2016 Oct; 355():i5534. PubMed ID: 27765788
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fractional flow reserve in different anatomical subsets.
    Lau JK; Yong AS
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e2-7. PubMed ID: 26247266
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myocardial scintigraphy for the assessment of perfusion in diabetic patients].
    Tebexreni AS; Smanio PE
    Arq Bras Endocrinol Metabol; 2004 Jun; 48(3):329-30. PubMed ID: 15658033
    [No Abstract]   [Full Text] [Related]  

  • 34. The association between coronary flow reserve and development of coronary calcifications: a follow-up study for 11 years in healthy young men.
    Uusitalo V; Saraste A; Kajander S; Luotolahti M; Wendelin-Saarenhovi M; Sundell J; Raitakari O; Knuuti J
    Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):812-8. PubMed ID: 23264601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractional flow reserve: concepts, applications and use in France in 2010.
    Puymirat É; Muller O; Sharif F; Dupouy P; Cuisset T; de Bruyne B; Gilard M
    Arch Cardiovasc Dis; 2010; 103(11-12):615-22. PubMed ID: 21147446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Heart; 2005 Dec; 91(12):1607-8. PubMed ID: 16287749
    [No Abstract]   [Full Text] [Related]  

  • 37. "Passive exercise" using whole body periodic acceleration: effects on coronary microcirculation.
    Fukuda S; Shimada K; Kawasaki T; Kono Y; Jissho S; Taguchi H; Maeda K; Yoshiyama M; Fujita M; Yoshikawa J
    Am Heart J; 2010 Apr; 159(4):620-6. PubMed ID: 20362721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vascular endothelium: a target organ for diabetes mellitus].
    Nitenberg A
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S13-7. PubMed ID: 12037502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of coronary artery flow using transthoracic Doppler echocardiography.
    Youn HJ; Foster E
    J Am Soc Echocardiogr; 2004 Feb; 17(2):178-85. PubMed ID: 14752494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary microvascular dysfunction portends poor prognosis in the setting of chronic renal failure: harnessing dual marker strategy for better risk-stratification?
    Yalta K; Yilmaz MB
    Int J Cardiol; 2014 Feb; 171(2):275-6. PubMed ID: 24342414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.